000 | 01934 a2200589 4500 | ||
---|---|---|---|
005 | 20250515233442.0 | ||
264 | 0 | _c20101230 | |
008 | 201012s 0 0 eng d | ||
022 | _a1464-3391 | ||
024 | 7 |
_a10.1016/j.bmc.2010.06.031 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNiculescu-Duvaz, Dan | |
245 | 0 | 0 |
_aNovel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry _cSep 2010 |
||
300 |
_a6934-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 | _aComputer Simulation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFurans _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xchemistry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemical synthesis |
650 | 0 | 4 | _aProtein Structure, Tertiary |
650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors |
650 | 0 | 4 |
_aPyrazoles _xchemical synthesis |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aNiculescu-Duvaz, Ion | |
700 | 1 | _aSuijkerbuijk, Bart M J M | |
700 | 1 | _aMénard, Delphine | |
700 | 1 | _aZambon, Alfonso | |
700 | 1 | _aNourry, Arnaud | |
700 | 1 | _aDavies, Lawrence | |
700 | 1 | _aManne, Helen A | |
700 | 1 | _aFriedlos, Frank | |
700 | 1 | _aOgilvie, Lesley | |
700 | 1 | _aHedley, Douglas | |
700 | 1 | _aTakle, Andrew K | |
700 | 1 | _aWilson, David M | |
700 | 1 | _aPons, Jean-Francois | |
700 | 1 | _aCoulter, Tom | |
700 | 1 | _aKirk, Ruth | |
700 | 1 | _aCantarino, Neus | |
700 | 1 | _aWhittaker, Steven | |
700 | 1 | _aMarais, Richard | |
700 | 1 | _aSpringer, Caroline J | |
773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 18 _gno. 18 _gp. 6934-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2010.06.031 _zAvailable from publisher's website |
999 |
_c20007549 _d20007549 |